PMID- 27175605 OWN - NLM STAT- MEDLINE DCOM- 20170327 LR - 20220317 IS - 1932-8737 (Electronic) IS - 0160-9289 (Print) IS - 0160-9289 (Linking) VI - 39 IP - 8 DP - 2016 Aug TI - Monitoring of Daily Body Weight and Intrathoracic Impedance in Heart Failure Patients With a High Risk of Volume Overload Decompensation. PG - 446-52 LID - 10.1002/clc.22547 [doi] AB - BACKGROUND: Decompensation is frequent in heart failure (HF) patients and predicts poor prognosis. HYPOTHESIS: Volume-overload events in HF patients are preceded by changes in intrathoracic impedance (Z) and body weight (BW); monitoring these parameters may be useful to predict decompensation. METHODS: Forty-three HF patients (LVEF 25% +/- 12%) with a recent HF event and an implantable cardioverter-defibrillator providing daily Z were equipped with telemonitoring scales submitting daily BW. Changes in BW and Z 30 days prior to major (HF hospitalization) and minor (ambulatory adjustment of diuretics) were analyzed. RESULTS: During median of 427 days follow-up 25 major and 41 minor events occurred. Z decreased by -4.8 (95% confidence interval [CI]: CI -6.7 to -3.0) and -4.3 (95% CI: -5.5 to -3.2) within 30 days prior to major and minor events respectively (P < 0.001). BW increased before major events by 2.3 kg (95% CI: 1.0 to 3.5, P < 0.01) and minor events 1 kg (95% CI: 0.5 to 1.4, P < 0.001). Sensitivity of Z for major/minor HF events was 83.3% (95% CI: 71.7 to 91.0) and for BW 43.9% (95% CI: 31.9 to 56.7). The unexplained detection rate per patient-year was 1.6 (interquartile range [IQR], 0-3.1) for Z and 4.8 (IQR 1.6-11.1) for BW. Combined Z and BW sensitivity was 42.4% (95% CI: 30.6 to 55.2) and unexplained detection rate was 0.8 (IQR, 0-1.5) per patient-year. CONCLUSIONS: Decompensation is marked by a decrease in Z and increase in BW the preceding 30 days. Monitoring of Z predicts HF decompensations with better sensitivity and lower unexplained detection rate than BW. CI - (c) 2016 Wiley Periodicals, Inc. FAU - Gudmundsson, Kristjan AU - Gudmundsson K AD - Karolinska Institute, Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden. FAU - Lynga, Patrik AU - Lynga P AD - Department of Clinical Science and Education (Lynga), Stockholm South General Hospital, Stockholm, Sweden. FAU - Rosenqvist, Marten AU - Rosenqvist M AD - Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden. FAU - Braunschweig, Frieder AU - Braunschweig F AD - Karolinska Institute, Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden. LA - eng PT - Journal Article DEP - 20160513 PL - United States TA - Clin Cardiol JT - Clinical cardiology JID - 7903272 RN - 0 (Diuretics) SB - IM MH - Aged MH - Cardiac Resynchronization Therapy MH - Cardiac Resynchronization Therapy Devices MH - *Cardiography, Impedance/instrumentation MH - Defibrillators, Implantable MH - Diuretics/therapeutic use MH - Electric Countershock/instrumentation MH - Female MH - Heart Failure/*diagnosis/physiopathology/therapy MH - *Hemodynamics MH - Humans MH - Male MH - Middle Aged MH - Predictive Value of Tests MH - Registries MH - Reproducibility of Results MH - Stroke Volume MH - Sweden MH - *Telemetry/instrumentation MH - Time Factors MH - Treatment Outcome MH - Ventricular Function, Left MH - *Water-Electrolyte Balance/drug effects MH - *Weight Gain/drug effects PMC - PMC6490859 EDAT- 2016/05/14 06:00 MHDA- 2017/03/28 06:00 PMCR- 2016/05/13 CRDT- 2016/05/14 06:00 PHST- 2015/10/02 00:00 [received] PHST- 2016/03/14 00:00 [revised] PHST- 2016/05/14 06:00 [entrez] PHST- 2016/05/14 06:00 [pubmed] PHST- 2017/03/28 06:00 [medline] PHST- 2016/05/13 00:00 [pmc-release] AID - CLC22547 [pii] AID - 10.1002/clc.22547 [doi] PST - ppublish SO - Clin Cardiol. 2016 Aug;39(8):446-52. doi: 10.1002/clc.22547. Epub 2016 May 13.